Plexus Corp. PLXS
263.09
1.48
0.57%
as of 25 Sep
- Market cap
- $7.0B
- P/E
- 38.0×
Follow PLXS
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
22.61 | 22.41 | 29.02 | 43.45 |
P/S ratio |
0.97 | 0.95 | 1.26 | 1.75 | |
P/FCF ratio |
25.41 | 51.58 | 71.50 | 129.81 | |
P/Operating CF |
29.63 | (255.81) | 190.41 | 310.00 | |
P/B ratio |
2.69 | 2.66 | 3.64 | 5.25 | |
Price to Tangible BV |
2.70 | 2.67 | 3.66 | 5.28 | |
EV/Sales |
0.93 | 0.93 | 1.24 | 1.74 | |
EV/EBITDA |
13.36 | 13.36 | 17.81 | 26.01 | |
EV/Operating CF |
15.02 | 21.33 | 31.11 | 46.74 | |
EV/FCF |
24.31 | 50.38 | 70.59 | 129.18 | |
Quick Ratio |
0.63 | 0.60 | 0.59 | 0.57 | |
Current Ratio |
1.58 | 1.59 | 1.54 | 1.49 | |
Net Debt/EBITDA |
(2.33) | (1.24) | (0.85) | (0.49) | |
Debt/Assets |
4.39% | 4.96% | 6.97% | 7.58% | |
Debt/Equity |
0.09 | 0.11 | 0.16 | 0.18 | |
Asset Turnover |
1.28 | 1.32 | 1.34 | 1.36 | |
Operating CF/Net income |
2.57 | (0.37) | 0.57 | 0.60 | |
Capex/Depreciation |
(1.81) | (1.83) | (0.65) | (1.41) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
4.88% | 4.83% | 4.93% | 5.37% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.74% | 0.73% | 0.68% | 1.62% | |
Graham Net Nets |
0.18 | 0.19 | 0.14 | 0.10 | |
Graham Number |
88.02 | 90.37 | 93.51 | 94.40 | |
Earnings Yield |
4.42% | 4.46% | 3.45% | 2.30% | |
Free Cash Flow Yield |
3.94% | 1.94% | 1.40% | 0.77% | |
Revenue per Share |
39.14 | 39.97 | 43.49 | 48.85 | |
Operating CF per Share |
4.88 | (0.57) | 1.06 | 0.97 | |
Capex per Share |
(1.29) | (1.31) | (0.47) | (1.00) | |
Free Cash Flow per Share |
3.59 | (1.89) | 0.60 | (0.03) | |
Cash per Share |
11.35 | 9.32 | 11.33 | 11.78 | |
Shareholders Equity per Share |
53.80 | 55.33 | 55.68 | 57.23 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
53.80 | 55.33 | 55.68 | 57.23 | |
Free Cash Flow |
97.20 | (50.58) | 16.01 | (0.75) | |
Working Capital |
880.11 | 913.01 | 924.92 | 949.58 | |
Capital Expenditures |
(34.82) | (35.19) | (12.45) | (26.66) | |
Net Current Asset Value |
716.27 | 751.73 | 766.03 | 790.50 | |
EV/EBIT |
18.50 | 18.30 | 23.99 | 34.65 | |
Capex to Sales |
0.03 | 0.03 | 0.01 | 0.02 | |
Net Profit Margin |
4.86% | 3.85% | 4.28% | 3.30% | |
Price to Operating Income |
19.33 | 18.74 | 24.30 | 34.82 | |
| Other line items | |||||
Average Receivables |
639.47 | 638.57 | 655.92 | 729.35 | |
Average Payables |
666.49 | 705.88 | 765.99 | 850.58 | |
Average Inventory |
1,270.64 | 1,297.76 | 1,327.06 | 1,383.31 | |
Average Assets |
3,145.47 | 3,128.64 | 3,223.35 | 3,369.62 | |
Average Common Equity |
1,389.71 | 1,400.07 | 1,420.74 | 1,473.92 |
Columns are period end dates